FDA pulls preterm-birth drug Makena and its generics from market after 12 years
The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12…
Read more FDA pulls preterm-birth drug Makena and its generics from market after 12 years